新型冠状病毒肺炎作为病毒性脓毒症病因:系统综述与Meta分析
本系统综述与Meta分析共纳入151篇文章,旨在描述COVID-19相关脓毒症的患病率。主要终点为ICU和普通病房住院成人中COVID-19相关脓毒症的患病率。结果显示,ICU患者脓毒症患病率为77.9%(95%CI 75.9-79.8),普通病房为33.3%(95%CI 30.3-36.4);普通病房患者中17.7%需转入ICU。ICU中最常见的器官功能障碍为ARDS(87.5%)。结论认为多数ICU住院的COVID-19患者符合Sepsis-3标准并存在感染相关器官功能障碍,应系统报告病毒性脓毒症。
要点
- ICU住院的COVID-19成人中,77.9%(95%CI 75.9-79.8)符合Sepsis-3或感染相关器官功能障碍需器官支持的标准。
- 普通病房住院的COVID-19成人中,33.3%(95%CI 30.3-36.4)符合脓毒症标准。
- 普通病房患者中17.7%(95%CI 12.9-23.6)需要转入ICU。
- ICU中最常见的器官功能障碍为ARDS,患病率87.5%(95%CI 83.3-90.7)。
- 仅5项研究直接报告脓毒症患病率,异质性高(I2最高达100%),结果需谨慎解读。
适用人群与场景
- 确诊COVID-19的成人住院患者,包括ICU和普通病房患者。
- 纳入标准:根据Sepsis-3诊断脓毒症,或存在感染相关器官功能障碍需要器官支持/替代治疗。
- 排除人群:原文未提及。
诊断标准与关键阈值
- 脓毒症诊断依据Sepsis-3标准,或感染相关器官功能障碍需要器官支持/替代治疗。
- 原文未提及具体的评分界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 普通病房患者中约18%需转入ICU,需密切监测病情变化。
研究设计与关键结果
- 研究类型:系统综述与Meta分析,检索MEDLINE、Cochrane、Google Scholar,最终分析151篇文章,仅5篇直接报告脓毒症患病率。
- 主要终点:ICU患者COVID-19相关脓毒症患病率为77.9%(95%CI 75.9-79.8;I2=91%;57项研究);普通病房为33.3%(95%CI 30.3-36.4;I2=99%;86项研究)。
- 关键次要终点:普通病房患者ICU转入率为17.7%(95%CI 12.9-23.6;I2=100%);ICU中ARDS患病率为87.5%(95%CI 83.3-90.7;I2=98%)。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:系统综述与Meta分析,纳入观察性研究,采用Newcastle-Ottawa量表和MINORS评估质量。
- 证据等级或推荐强度:原文未提及。
- 局限:仅5项研究直接报告脓毒症患病率;异质性高(I2 91%-100%);原文未提及纳入研究的设计类型、单中心/多中心等细节。
对床旁实践的改变
- 应认识到ICU住院的COVID-19患者大多数符合Sepsis-3标准,需按脓毒症进行器官功能评估和支持治疗。
- 普通病房COVID-19患者中约三分之一符合脓毒症标准,且近五分之一需转入ICU,应加强监测和及时升级治疗。
- 应系统报告病毒性脓毒症,以便预后评估和治疗决策。
- 原文未提及具体治疗药物或剂量,不改变现有脓毒症集束化治疗。
指南或共识出处
- 系统综述与Meta分析,注册号CRD42020202018,检索数据库包括MEDLINE (PubMed)、Cochrane和Google Scholar。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review.
DATA SOURCES: MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD42020202018).
STUDY SELECTION: Studies reporting on patients with confirmed coronavirus disease 2019 diagnosed with sepsis according to sepsis-3 or according to the presence of infection-related organ dysfunctions necessitating organ support/replacement were included in the analysis. The primary end point was prevalence of coronavirus disease 2019-related sepsis among adults hospitalized in the ICU and the general ward. Among secondary end points were the need for ICU admission among patients initially hospitalized in the general ward and the prevalence of new onset of organ dysfunction in the ICU. Outcomes were expressed as proportions with respective 95% CI.
DATA EXTRACTION: Two reviewers independently screened and reviewed existing literature and assessed study quality with the Newcastle-Ottawa Scale and the Methodological index for nonrandomized studies.
DATA SYNTHESIS: Of 3,825 articles, 151 were analyzed, only five of which directly reported sepsis prevalence. Noting the high heterogeneity observed, coronavirus disease 2019-related sepsis prevalence was 77.9% (95% CI, 75.9-79.8; I2 = 91%; 57 studies) in the ICU, and 33.3% (95% CI, 30.3-36.4; I2 = 99%; 86 studies) in the general ward. ICU admission was required for 17.7% (95% CI, 12.9-23.6; I2 = 100%) of ward patients. Acute respiratory distress syndrome was the most common organ dysfunction in the ICU (87.5%; 95% CI, 83.3-90.7; I2 = 98%).
CONCLUSIONS: The majority of coronavirus disease 2019 patients hospitalized in the ICU meet Sepsis-3 criteria and present infection-associated organ dysfunction. The medical and scientific community should be aware and systematically report viral sepsis for prognostic and treatment implications.
参考来源
- Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis. Crit Care Med. 2021. PMID: 34259663. doi:10.1097/CCM.0000000000005195
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。